{"version":"1.0","type":"link","title":"A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer.","author_name":"Yang L 외","author_url":"https://prs-insight.online/author/Yang%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76077","thumbnail_width":1200,"thumbnail_height":630}